Skip to main content
. 2022 Jan 6;12(1):90. doi: 10.3390/biom12010090

Figure 4.

Figure 4

Schematic representation of shogaol conjugates formation (M2) and their ability to inhibit colony formation in human colon cancer cell (HCT-116) with doses ranging from 0 to 40 μM over 2 weeks.